Overall, we found that AML cells had an active reductive TCA cycle catalyzed by the highly expressed wt-IDH2, which promoted lipid synthesis and c-Myc expression through timely conversion of α-KG from glutamine to isocitrate/citrate. The gene discussed is MYC; the disease is acute myeloid leukemia.